Diligence memo · auto-generated · as of July 2, 2026

SpIntellx, Inc.

SpIntellx, Inc. looks over-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

SpIntellx, Inc. operates in Other Health Care, based in PITTSBURGH.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

SpIntellx, Inc. has raised $2.0M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $601K on 2023-08-04.

Most recent recorded round closed around 2023-08-04.

Valuation (modeled)modeled

Provath models SpIntellx, Inc. at approximately $4.0M (range $377K–$18M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.56× the median modeled value of Pre-Seed Other Health Care companies in 2022–2024 (288 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 15 months.

Last raise 2.9 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round stepped up 2.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 46% of Other Health Care peers (5377 compared).

Modeled value ranks above 18% of those peers.

Closest niche peers: Active Recovery TMS, LLC, Imagen Walled Lake Support Services, LLC, Pinnacle Integrated Medicine, Inc., Choix, Inc., DataBiologics, Inc..

Peoplefiled

8 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.